Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients by Nathan Holthaus, Kurt W. Prins, Lauren Rose, Sasha Prisco, Marc Pritzker, Thenappan Thenappan

Get full text

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again by Kurt W. Prins, Thenappan Thenappan, E. Kenneth Weir, Rajat Kalra, Marc Pritzker, Stephen L. Archer

Get full text

Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease by Kurt W. Prins, Lauren Rose, Stephen L. Archer, Marc Pritzker, E. Kenneth Weir, Matthew D. Olson, Thenappan Thenappan

Get full text

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies by Thenappan Thenappan, Nadine Al-Naamani, Stefano Ghio, Hossein-Ardeschir Ghofrani, Paul M. Hassoun, Marc Pritzker, Adam Torbicki, Sylvia Nikkho, Dennis Busse, Ioana R. Preston

Get full text

Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension by Kurt W. Prins, Rajat Kalra, Lauren Rose, Tufik R. Assad, Stephen L. Archer, Navkaranbir S. Bajaj, E. Kenneth Weir, Sasha Z. Prisco, Marc Pritzker, Pamela L. Lutsey, Evan L. Brittain, Thenappan Thenappan

Get full text